GENSIGHT BIOLOGICS S.A. (EPA:SIGHT)

PRESS RELEASE

published on 09/27/2024 at 11:24, 2 years 1 month ago

HALF-YEAR_FINANCIAL_REPORT_JUNE_2024
BRIEF

published on 09/23/2024 at 19:41, 2 years 1 month ago

GenSight Biologics Reports Interim Financial Results for H1 2024

Financial Results Cash Management LUMEVOQ® Early Access Program R&D Expenses
PRESS RELEASE

published on 09/23/2024 at 19:36, 2 years 1 month ago

Inside Information / News release on accounts, results
GenSight Biologics reports interim financial results for the first half of 2024, highlighting optimized cash management, extension of cash runway, and upcoming LUMEVOQ® drug product release

Cash Management GenSight Biologics Interim Financial Results LUMEVOQ® Drug Product Release
BRIEF

published on 09/17/2024 at 14:45, 2 years 1 month ago

Goldman Sachs sells its GENSIGHT BIOLOGICS SA shares

Euronext Paris Goldman Sachs Crossing Thresholds Transfer Of Shares GenSight Biologics
BRIEF

published on 07/23/2024 at 07:35, 2 years 3 months ago

GenSight Biologics Reports Financial Position and Business Progress

Gene Therapy Financial Update GenSight Biologics LUMEVOQ Early Access Program
PRESS RELEASE

published on 07/23/2024 at 07:30, 2 years 3 months ago

Inside Information / News release on accounts, results
GenSight Biologics reports cash position of €6.9 million as of June 30, 2024, with potential over 100 vials available upon Q3 resumption of early access program. Company confirms sufficient working capital and successful blending step for LUMEVOQ drug product

Working Capital Business Update Cash Position GenSight Biologics LUMEVOQ Drug Product
BRIEF

published on 07/11/2024 at 07:35, 2 years 3 months ago

GenSight Biologics Launches Newsletter for Retail Investors

Financial Updates Gene Therapy Retail Investors LUMEVOQ® Optogenetics
PRESS RELEASE

published on 07/11/2024 at 07:30, 2 years 3 months ago

Inside Information / Other news releases
GenSight Biologics launches a newsletter for retail investors providing updates, news articles, conferences, and financial figures in French, available via subscription on the company's website

Subscription Retail Investors Newsletter French GenSight Biologics
BRIEF

published on 06/20/2024 at 07:35, 2 years 4 months ago

GenSight Biologics Renegotiates Financial Obligations and Provides Operational Updates

Gene Therapy Operational Update GenSight Biologics Financial Negotiation
PRESS RELEASE

published on 06/20/2024 at 07:30, 2 years 4 months ago

Inside Information / Other news releases
GenSight Biologics renegotiates financial obligations and provides operational updates, with successful capital increases enhancing short-term flexibility

Financial Obligations Operational Updates GenSight Biologics Capital Increases Gene Therapies

Published on 10/30/2026 at 23:35, 1 day 14 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 15 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 1 day 17 hours ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 1 day 19 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 23 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/01/2026 at 10:35, 3 hours 55 minutes ago

Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 9 hours 30 minutes ago

2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 21 hours 55 minutes ago

SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 15 hours ago

EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 22:30, 1 day 16 hours ago

/C O R R E C T I O N - OCI Global/

View all EQS

Published on 10/30/2026 at 23:00, 1 day 15 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 1 day 17 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 1 day 20 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 2 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 2 days 5 hours ago

Share buyback

View all LES ECHOS COMFI WIRE

News